INDUSTRY-LEADING TruRhythm DETECTION
episode review without sacrificing sensitivity.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Patients with asymptomatic episodes are at equal risk for stroke as symptomatic patients.1
Continuous cardiac monitoring leads to more actionable events than conventional monitoring.6
Build a diagnostic picture by continuously monitoring AF burden, heart rate variability, and daily activity with Reveal LINQ™ insertable cardiac monitor (ICM).
Reveal LINQ ICM provides physicians with longitudinal data to objectively determine both asymptomatic and symptomatic AF. This data results in the measure of true AF burden and accurate characterization of the AF type to effectively guide therapy decisions.3,7
Heart rate variability
Median ventricular interval calculated every 5 minutes.
Reveal LINQ ICM allows physicians to continually monitor the ongoing change in AF burden so that treatment can be initiated or changed on a timely basis.8-10
Allow for customization by clinic and/or individual patient.
Smart filtering algorithm improves detection accuracy for Brady & Pause.
Streamlined episodes & report updates simplify data review.
Significantly reduce false positives while preserving sensitivity.10,11
Based on clinical evidence.
Medtronic CareAlert™ notifications are not intended to be used as the sole basis for making decisions about patient medical care.
Reveal LINQ has been demonstrated to pose no known hazards in a specified MRI environment with specified conditions of use. Please see the Reveal™ ICM clinician manual or MRI technical manual for more details.
Bakhai A, Darius H, De Caterina R, et al. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms. Eur Heart J Qual Care Clin Outcomes. October 1, 2016;2(4):299-305.
Tondo C, Tritto M, Landolina M, et al. Rhythm-symptom correlation in patients on continuous monitoring after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. February 2014;25(2):154-160.
Verma A, Champagne J, Sapp J, et al. Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation Before and After Catheter Ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med. January 28, 2013;173(2):149-156.
Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm. April 2012;9(4):632-696.
Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/ SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. January 1, 2018;20(1):e1-e160.
Kapa S, Epstein AE, Callans DJ, et al. Assessing arrhythmia burden after catheter ablation of atrial fibrillation using an implantable loop recorder: the ABACUS study. J Cardiovasc Electrophysiol. August 2013;24(8):875-881.
Wechselberger S, Kronborg M, Huo Y, et al. Continuous monitoring after atrial fibrillation: the LINQ AF study. Europace. November 1, 2018;20(FI_3):f312-f320.
Sinha S. The Impact of Atrial Fibrillation: Paroxysmal Atrial Fibrillation: Diagnosis, Progression, and Stroke Risk. MedPageToday. Available at: https://archive.li/DU7LI. Accessed February 25, 2019.
Mascarenhas DA, Farooq MU, Ziegler PD, Kantharia BK. Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding. Europace. June 2016;18(6):799-806.
Passman R, Bernstein RA. New Appraisal of Atrial Fibrillation Burden and Stroke Prevention. Stroke. February 2016;47(2):570-576.
Pürerfellner H, Sanders P, Sarkar S, et al. Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors. Europace. November 1, 2018;20(Fl_3):f321-f328.
Passman RS, Rogers JD, Sarkar S, et al. Development and validation of a dual sensing scheme to improve accuracy of bradycardia and pause detection in an insertable cardiac monitor. Heart Rhythm. July 2017;14(7):1016-1023.
TruRhythm Detection Algorithms. Medtronic data on file. 2017.
Reference the Reveal LINQ ICM Clinician Manual for usage parameters.